Oval Medical Advanced Epinephrine Autoinjector Proof of Market

Oval的先进肾上腺素自动注射器旨在解决严重过敏性休克导致死亡的一些根本原因（过敏反应），特别是在青少年和年轻人的高风险群体中。这一群体的风险特别高，因为：- 年轻一代过敏发生率上升-该年龄组的依从性和对风险的态度较差-在没有先前经验或定期培训的情况下难以使用一些现有的肾上腺素自动注射器-害怕自我注射基于对该市场人为因素的广泛经验，Oval提出了一种新颖的方法来解决这些问题。这个项目将使我们能够测试这种方法并了解新设备的可能有效性和可接受性

Oval's advanced Epinephrine Autoinjector is intended to address some of the fundamentalcauses of fatalities due to severe anaphylactic shock (allergic reaction), particularly in the highrisk group of teenagers and young adults.This group is particularly at risk due to:- Rising incidence of allergy in younger generations- Poor compliance and attitude to risk of this age group- Difficulty in using some existing Epinephrine Autoinjectors without previous experience orregular training- Fear of self-injectionBased on extensive experience of human factors in this market, Oval has generated a novelapproach to address many of these issues. This project will allow us to test this approach andunderstand the likely effectiveness and acceptability of a new device